RANI: Rani Therapeutics Holdings Amount of Cash per Share

Corporate emblem and logo of Rani Therapeutics Holdings (RANI)

Growth prospects for Rani Therapeutics (RANI) rely on the commercialization of the RaniPill robotic capsule for the contactless administration of biologics. Cash per share trends demonstrate financial resilience, with the 0.33 mark recording this metric. Stability is underpinned by hundreds of patents and the successful completion of FDA reviews, while a strategic focus on partnerships with pharma behemoths minimizes direct price competition within the oral dosage segment.

RANI: ranitherapeutics.com Cash per Share 07/04/2022 - 11/20/2026

Analytical breakdowns for Rani Therapeutics

- cash position and cash flow details:
Summary company analysis:RANI, Rani Therapeutics Holdings
Original product of Rani Therapeutics

Geopolitical risks and supply chain disruptions make Rani Therapeutics (RANI) dependent on maintaining reserves for clinical trials. This metric is calculated by dividing the total cash balance by the total number of shares outstanding. This indicator determines the real liquidity of each share, assessing the business's ability to operate without external financing. Excess cash guarantees survival but may limit return on equity. By analyzing the cash per share, an investor evaluates the company's resilience to external shocks.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)